共 108 条
[1]
Peel NM(2011)Epidemiology of falls in older age Can J Aging 30 7-19
[2]
McDonnell CC(2020)The fall risk with alpha blockers given initial dose or elderly status (FRAGILE) study Ann Pharmacother 54 226-231
[3]
Rogers KC(1994)The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype Mol Pharmacol 45 703-708
[4]
Regen SM(2009)Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease Rev Urol 11 S9-S13
[5]
Finks SW(2000)Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature J Urol 164 578-583
[6]
Forray C(2006)The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia Rev Urol 8 S3-9
[7]
Bard JA(1987)Prazosin in the treatment of prostatic obstruction. A placebo-controlled study Br J Urol 60 136-142
[8]
Wetzel JM(2016)Alpha-blockers for the treatment of benign prostatic hyperplasia Urol Clin N Am 43 311-323
[9]
Chiu G(2008)Alpha1-adrenoceptor subtypes and lower urinary tract symptoms Int J Urol 15 193-199
[10]
Shapiro E(2013)Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40–85 years in the United States: risk window analyses using between and within patient methodology BMJ 347 446-450